Nutraceuticals CDMO Market to grow with a CAGR of 7.87% through 2029

Growing demand of development of the nutraceutical products and to ensure the quality standard are factors driving the growth of Global Nutraceuticals CDMO Market in the forecast period, 2025-2029.

According to TechSci Research report, “Nutraceuticals CDMO Market –Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2029F”, the Global Nutraceuticals CDMO Market stood at USD 34.09 Billion in 2023 and is anticipated to projected at an impressive CAGR 7.87% growth in the forecast period through 2029. This can be ascribed to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

The nutraceuticals CDMO market is heavily influenced by regulatory frameworks and quality assurance standards governing the production, labeling, and marketing of nutraceutical products. Regulatory support plays a crucial role in providing assurance to consumers regarding the safety, efficacy, and quality of the products they purchase. Many governments worldwide have established regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Food Safety Authority (EFSA) in the European Union, to oversee the nutraceuticals industry and ensure compliance with established standards. These regulations encompass various aspects, including good manufacturing practices (GMP), labeling requirements, and permissible ingredients and dosages.

Regulatory bodies continuously update and revise existing regulations to reflect advances in scientific research, technological innovation, and emerging safety concerns. This creates a dynamic regulatory environment that necessitates ongoing compliance and adaptation by nutraceutical CDMOs to meet evolving standards and requirements. Adherence to quality assurance protocols and certification programs, such as ISO 9001, NSF International, and US Pharmacopeia (USP), demonstrates a commitment to product quality, safety, and consistency. These certifications enhance the credibility and trustworthiness of nutraceutical companies in the eyes of consumers and regulatory authorities alike.

Regulatory support for health claims and functional ingredients further drives innovation and market growth within the nutraceuticals industry. Governments may authorize specific health claims based on scientific evidence supporting the beneficial effects of certain nutrients or bioactive compounds on human health, thereby encouraging the development and marketing of related products by nutraceutical CDMOs.

Ingredient sourcing and supply chain disruptions can present significant challenges to the Global Nutraceutical CDMO (Contract Development and Manufacturing Organization) market. The nutraceutical industry relies on a diverse range of raw materials, including botanicals, extracts, vitamins, minerals, and other bioactive compounds. The reliability and consistency of ingredient suppliers can vary, affecting the quality and availability of essential components for nutraceutical formulations. Many nutraceutical ingredients are derived from natural sources and may be subject to seasonal variations in availability and quality. This can lead to challenges in maintaining consistent product formulations and meeting production timelines.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global Nutraceuticals CDMO Market”

The Global Nutraceuticals CDMO Market segmentation is based on dosage form, service, company size, regional distribution and company.

Based on company size, In the forecast period for the Global Nutraceuticals Contract Development and Manufacturing Organization (CDMO) Market, mid-sized companies are anticipated to dominate. While large companies may possess substantial resources and established infrastructures, mid-sized companies often offer a balance of flexibility, agility, and expertise that enables them to effectively cater to the dynamic needs of the nutraceuticals industry. Mid-sized companies typically have the capacity to innovate and adapt quickly to changing market trends, allowing them to capitalize on emerging opportunities and address niche segments within the nutraceuticals market. Their streamlined organizational structures and less bureaucratic processes facilitate faster decision-making and execution, enabling them to remain competitive in a rapidly evolving landscape. Mid-sized companies often specialize in niche areas or provide specialized services within the nutraceuticals CDMO market, allowing them to differentiate themselves and carve out a distinct market position. This specialization enables them to deliver tailored solutions and high-quality services that meet the unique requirements of their clients, driving customer satisfaction and loyalty. Mid-sized companies may form strategic partnerships or collaborations with larger corporations or research institutions to leverage complementary strengths and resources, further enhancing their competitive advantage and market presence.

North America's anticipated dominance in the forecast period of the Global Nutraceuticals Contract Development and Manufacturing Organization (CDMO) Market can be attributed to several factors.  North America has a strong consumer demand for nutraceutical products, fueled by increasing awareness of health and wellness, rising disposable incomes, and a growing aging population. Consumers in the region are increasingly turning to dietary supplements, functional foods, and other nutraceutical products to address various health concerns and improve overall well-being. Favorable regulatory frameworks and supportive government policies in North America facilitate market growth and investment in the nutraceuticals CDMO sector. Regulatory agencies such as the Food and Drug Administration (FDA) in the United States provide clear guidelines and oversight, ensuring product safety and quality while also fostering innovation and market expansion.

Some of the major companies operating in the Global Nutraceuticals CDMO Market include:

·         Catalent Inc.

·         Lonza Group AG

·         NUTRASCIENCE LABS Inc

·         Robinson Pharma, Inc.

·         Health Wright Products, Inc.

·         Innovations in Nutrition + Wellness

·         INPHARMA S.p.A.

·         Aenova Group

·         NutraPakUSA

·         SFI Health Pty Ltd.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Functional foods and beverages, which offer health benefits beyond basic nutrition, are gaining popularity among consumers seeking convenient and effective ways to improve their well-being. This trend is driving demand for nutraceutical ingredients that can be incorporated into a wide range of food and beverage products, including fortified snacks, beverages, dairy products, and meal replacements. CDMOs are capitalizing on this trend by expanding their capabilities to develop and manufacture functional ingredients and finished products for food and beverage companies. By collaborating with food scientists, nutritionists, and culinary experts, CDMOs can create innovative formulations that combine nutritional benefits with great taste and convenience. This enables food and beverage brands to differentiate themselves in the market and meet the evolving needs of health-conscious consumers", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets & Capsules, Powder, Softgel, Others), By Service (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance, Others), By Company Size (Small Companies, Mid-Sized Companies, Large Companies), By Region, and Competition, 2019-2029F” has evaluated the future growth potential of Global Nutraceuticals CDMO Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Nutraceuticals CDMO Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com